glp-1 health risks INFOGRAPHIC: The Hidden of Weight Loss Medications GLP-1 Medications: Everything You Need

Data on using tirzepatide while nursing are limited because most clinical trials exclude breastfeeding parents

Talk to your healthcare provider to see if you are an ideal candidate for these drugs

A synthesis of preclinical and population-level evidence now indicates that these agents may influence the development and progression of several OACs, particularly hepatocellular carcinoma (HCC), pancreatic cancer, and colorectal cancer (CRC)

Full doses of these medications can cause gastrointestinal issues, such as nausea, vomiting, and diarrhea

It is available in two formulations: a once-weekly subcutaneous injection (Wegovy for obesity, Ozempic for type 2 diabetes) and a daily oral tablet (Rybelsus for type 2 diabetes)